Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis: A Prospective Multi-Center Observational Comparative Study

NCT07037823 is registered in ClinicalTrials.gov with Ying Gao as lead sponsor.

NCT NCT07037823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07037823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis: A Prospective Multi-Center Observational Comparative Study
Lead sponsor
Ying Gao
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
December 31, 2026
Enrollment
328 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rrms